Conditions: Binge Eating Disorder
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 271
Healthy volunteers: no

Brief summary:
To evaluate the efficacy of SPD489 compared to placebo in the treatment of moderate to severe binge eating disorder as measured by the number of binge days per week

Detailed description:

Arms:
arm 1: None arm 2: None arm 3: None arm 4: None

Interventions: intervention 1: lisdexamfetamine dimesylate (SPD489) intervention 2: lisdexamfetamine dimesylate (SPD489) intervention 3: lisdexamfetamine dimesylate (SPD489) intervention 4: Placebo
Intervention descriptions: intervention 1: SPD489-30mg capsules taken once daily for up to 11 weeks intervention 2: SPD489 50mg capsules taken once-daily for up to 11 weeks intervention 3: SPD489 70mg capsule taken once-daily for up to 11 weeks intervention 4: Placebo capsule taken once daily for up to 11 weeks

Protocol document: